Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance

DG Hernandez, X Reed… - Journal of …, 2016 - Wiley Online Library
Parkinson's disease is a common, progressive neurodegenerative disorder, affecting 3% of
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …

[HTML][HTML] Pathological roles of MAPK signaling pathways in human diseases

EK Kim, EJ Choi - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2010 - Elsevier
The mammalian family of mitogen-activated protein kinases (MAPKs) includes extracellular
signal-regulated kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK), with each MAPK …

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

M Steger, F Tonelli, G Ito, P Davies, M Trost, M Vetter… - elife, 2016 - elifesciences.org
Mutations in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2)
protein, comprise the predominant genetic cause of Parkinson's disease (PD). G2019S, the …

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

N Exner, AK Lutz, C Haass, KF Winklhofer - The EMBO journal, 2012 - embopress.org
Neurons are critically dependent on mitochondrial integrity based on specific morphological,
biochemical, and physiological features. They are characterized by high rates of metabolic …

What genetics tells us about the causes and mechanisms of Parkinson's disease

O Corti, S Lesage, A Brice - Physiological reviews, 2011 - journals.physiology.org
Parkinson's disease (PD) is a common motor disorder of mysterious etiology. It is due to the
progressive degeneration of the dopaminergic neurons of the substantia nigra and is …

LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same

DC Berwick, GR Heaton, S Azeggagh… - Molecular …, 2019 - Springer
Since the discovery of leucine-rich repeat kinase 2 (LRRK2) as a protein that is likely central
to the aetiology of Parkinson's disease, a considerable amount of work has gone into …

LRRK2 inhibition attenuates microglial inflammatory responses

MS Moehle, PJ Webber, T Tse, N Sukar… - Journal of …, 2012 - Soc Neuroscience
Missense mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's
disease (PD), and common genetic variation in LRRK2 modifies susceptibility to Crohn's …

LRRK2 regulation of immune-pathways and inflammatory disease

RL Wallings, MG Tansey - Biochemical Society Transactions, 2019 - portlandpress.com
Mutations in the leucine-rich-repeat kinase 2 (LRRK2) gene are associated with familial and
sporadic cases of Parkinson's disease but are also found in immune-related disorders such …

Protein phosphorylation in neurodegeneration: friend or foe?

S Tenreiro, K Eckermann, TF Outeiro - Frontiers in molecular …, 2014 - frontiersin.org
Protein misfolding and aggregation is a common hallmark in neurodegenerative disorders,
including Alzheimer's disease (AD), Parkinson's disease (PD), and fronto-temporal dementia …

Recent advances in the genetics of Parkinson's disease

I Martin, VL Dawson, TM Dawson - Annual review of genomics …, 2011 - annualreviews.org
Genetic studies have provided valuable insight into the pathological mechanisms underlying
Parkinson's disease (PD). The elucidation of genetic components to what was once largely …